Order Article Reprints

Chang C-J, Hsu W-F, Jeng L-B, Lai H-C, Hsu S-C, Chen T-H, Wang H-W, Peng C-Y. Adjuvant Sorafenib for Postoperative Patients with Hepatocellular Carcinoma and Macrovascular Invasion. Current Oncology. 2023; 30(12):10134-10141. https://doi.org/10.3390/curroncol30120737

Chang, Che-Jui, Wei-Fan Hsu, Long-Bin Jeng, Hsueh-Chou Lai, Shih-Chao Hsu, Te-Hung Chen, Hung-Wei Wang, and Cheng-Yuan Peng. 2023. "Adjuvant Sorafenib for Postoperative Patients with Hepatocellular Carcinoma and Macrovascular Invasion" Current Oncology 30, no. 12: 10134-10141. https://doi.org/10.3390/curroncol30120737

Chang, C. -J., Hsu, W. -F., Jeng, L. -B., Lai, H. -C., Hsu, S. -C., Chen, T. -H., Wang, H. -W., & Peng, C. -Y. (2023). Adjuvant Sorafenib for Postoperative Patients with Hepatocellular Carcinoma and Macrovascular Invasion. Current Oncology, 30(12), 10134-10141. https://doi.org/10.3390/curroncol30120737